Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Oral corticosteroids for multiple sclerosis relapse.
Testosterone Depletion Increases the Susceptibility of Brain Tissue to Oxidative Damage in a Restraint Stress Mouse Model.
CXXC5 plays a role as a transcription activator for myelin genes on oligodendrocyte differentiation.
Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
Optimizing treatment success in multiple sclerosis.
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study.
A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
Molecular genetic studies of multiple sclerosis in the portuguese population.
Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Ambulation in adults with central neurologic disorders.
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis.
[Quality of life in multiple sclerosis--association with clinical features, fatigue and depressive syndrome].
White Matter Changes in Patients with Friedreich Ataxia after Treatment with Erythropoietin.
Heart rate variability.
Identification of Bax-Interacting Proteins in Normal Oligodendrocyte Progenitors during Glutamate Excitotoxicity and Perinatal Hypoxia-Ischemia.
TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.
Placebo and nocebo effects in the neurological practice.
Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis.
Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
Is customized vestibular rehabilitation effective in patients with multiple sclerosis? A randomized controlled trial.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
Clinical and Radiological Characteristics in Multiple Sclerosis Patients with Large Cavitary Lesions.
Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications.
Pages
« first
‹ previous
…
503
504
505
506
507
508
509
510
511
…
next ›
last »